for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Microbot Medical Inc

MBOT.OQ

Latest Trade

6.55USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1.38

 - 

19.39

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
6.55
Open
--
Volume
--
3M AVG Volume
2.05
Today's High
--
Today's Low
--
52 Week High
19.39
52 Week Low
1.38
Shares Out (MIL)
4.31
Market Cap (MIL)
28.22
Forward P/E
-4.23
Dividend (Yield %)
--

Latest Developments

More

Microbot Medical Files For Offering Up To 996,016 Shares Of Common Stock

Microbot Medical Inc. Announces $2.5 Million Registered Direct Offering Priced At-The-Market

Microbot Medical Says Has Validated Operational Effectiveness Of Company's Self-Cleaning Shunt

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Microbot Medical Inc

Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company's TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

Industry

Biotechnology & Drugs

Contact Info

175 Derby St # 27/1

+1.908.9385561

http://www.microbotmedical.com/

Executive Leadership

Harel Gadot

Chairman of the Board, President, Chief Executive Officer

David Ben Naim

Chief Financial Officer

Simon Sharon

Chief Technology Officer

Yoseph Bornstein

Director

Scott R. Burell

Director

Key Stats

2.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2017

-2.700

2018

-2.410

2019(E)

-1.550
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
3.54
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-91.23
Return on Equity (TTM)
-69.74

Latest News

BRIEF-Microbot Medical Exercises Option To Buy Novel Technology From Cardiosert

* MICROBOT MEDICAL EXERCISES OPTION TO ACQUIRE NOVEL TECHNOLOGY FROM CARDIOSERT LTD. Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Microbot Medical Expects To Reach Development Milestones For Self Cleaning Shunt In Late 2018 Or Early 2019

* BELIEVES WILL REACH ANTICIPATED DEVELOPMENT MILESTONES FOR SELF-CLEANING SHUNT, SUBMISSION WITH FDA IN LATE 2018/EARLY 2019 Source text for Eikon: Further company coverage:

BRIEF-Microbot Medical Says ‍U.S. Patent And Trademark Office Issued A Notice Of Allowance Covering Company's Tipcat Technology Platform​

* MICROBOT MEDICAL INC - U.S. PATENT AND TRADEMARK OFFICE ISSUED A NOTICE OF ALLOWANCE COVERING COMPANY'S TIPCAT TECHNOLOGY PLATFORM Source text for Eikon: Further company coverage:

BRIEF-Microbot Medical receives additional government grant for development of its self-cleaning shunt

* Microbot Medical Inc receives additional government grant for development of its self-cleaning shunt Source text for Eikon: Further company coverage:

BRIEF-Microbot Medical Q2 loss per share $0.12

* Microbot Medical Inc reports second quarter 2017 financial results and recent development and strategic progress

BRIEF-Microbot Medical announces issuance of a Canadian patent covering a self-cleaning shunt

* Microbot Medical Inc. announces issuance of a Canadian patent covering a self-cleaning shunt Source text for Eikon: Further company coverage:

BRIEF-Microbot Medical reports Q1 loss per share $0.04

* Reports first quarter 2017 financial results and recent development progress

BRIEF-Microbot Medical files for mixed shelf of up to $75 mln

* Files for mixed shelf of up to $75.0 million - sec filing Source text (http://bit.ly/2oiCSkH) Further company coverage:

BRIEF-Microbot Medical appoints medical device veteran Martin Madden to board

* Microbot medical inc. Strengthens board of directors with medical device veteran martin j. Madden Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up